Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT03711604
Title Compassionate Use Study of Tenalisib (RP6530)
Recruitment Enrolling by invitation
Gender both
Phase Phase Ib/II
Variant Requirements No
Sponsors Rhizen Pharmaceuticals SA
Indications

hematologic cancer

Therapies

Tenalisib

Age Groups: adult | child | senior
Covered Countries USA


No variant requirements are available.